AU2003270876A1 - Anti-hla assay and methods - Google Patents

Anti-hla assay and methods

Info

Publication number
AU2003270876A1
AU2003270876A1 AU2003270876A AU2003270876A AU2003270876A1 AU 2003270876 A1 AU2003270876 A1 AU 2003270876A1 AU 2003270876 A AU2003270876 A AU 2003270876A AU 2003270876 A AU2003270876 A AU 2003270876A AU 2003270876 A1 AU2003270876 A1 AU 2003270876A1
Authority
AU
Australia
Prior art keywords
methods
hla assay
hla
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003270876A
Other versions
AU2003270876A8 (en
Inventor
Rico Buchli
Christopher Giberson
William H. Hildebrand
Rod Vangundy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/337,161 external-priority patent/US20060276629A9/en
Priority claimed from PCT/US2003/000243 external-priority patent/WO2003057852A2/en
Application filed by Individual filed Critical Individual
Publication of AU2003270876A8 publication Critical patent/AU2003270876A8/en
Publication of AU2003270876A1 publication Critical patent/AU2003270876A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70539—MHC-molecules, e.g. HLA-molecules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G01N2800/245—Transplantation related diseases, e.g. graft versus host disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003270876A 2002-09-24 2003-09-24 Anti-hla assay and methods Abandoned AU2003270876A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US41384202P 2002-09-24 2002-09-24
US60/413,842 2002-09-24
AU2003202892 2003-01-02
US10/337,161 2003-01-02
US10/337,161 US20060276629A9 (en) 1999-12-17 2003-01-02 Purification and characterization of soluble human HLA proteins
PCT/US2003/000243 WO2003057852A2 (en) 2001-12-18 2003-01-02 Purification and characterization of hla proteins
PCT/US2003/030096 WO2004029280A2 (en) 2002-09-24 2003-09-24 Anti-hla assay and methods

Publications (2)

Publication Number Publication Date
AU2003270876A8 AU2003270876A8 (en) 2004-04-19
AU2003270876A1 true AU2003270876A1 (en) 2004-04-19

Family

ID=32684708

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003270876A Abandoned AU2003270876A1 (en) 2002-09-24 2003-09-24 Anti-hla assay and methods

Country Status (2)

Country Link
AU (1) AU2003270876A1 (en)
WO (1) WO2004029280A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2467700A (en) 2007-11-09 2010-08-11 Baxter Int Modified recombinant Factor VIII and von Willebrand Factor and methods of use
CN102770448B (en) 2010-02-17 2016-11-16 美国莱姆德有限公司 For detecting compositions and the method for anti-natural human human leucocyte antigen antibody

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0814838T3 (en) * 1995-03-08 2003-09-15 Scripps Research Inst Antigen presenting system and activation of T cells

Also Published As

Publication number Publication date
WO2004029280A3 (en) 2004-07-15
AU2003270876A8 (en) 2004-04-19
WO2004029280A2 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
AU2003299778A1 (en) Antibodies against gpr64 and uses thereof
AU2003243736A1 (en) Improved assay systems and components
IL225633A0 (en) Anti-alpha-v-beta - 6 antibodies and uses thereof
EP1551447A4 (en) Anti-addl antibodies and uses thereof
AU2002314433A1 (en) Ephrin-tie receptor materials and methods
AU2003282478A1 (en) Discount-instrument methods and systems
WO2004040000A9 (en) G protein coupled receptors and uses thereof
AU2003226094A1 (en) Compounds and methods
AU2003297037A1 (en) Illuminant and method
AU2003296369A1 (en) Imminoamines and preparation thereof
IL166063A0 (en) Antibodies and uses thereof
AU2003267361A1 (en) Orthopoxvirus antigens and use thereof
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2003298739A1 (en) Intermedin and its uses
AU2003302173A1 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003262744A1 (en) Alpha-AMYLASE ASSAY AND USES THEREOF
AU2003284597A1 (en) Apoptosis-associated protein and use thereof
AU2003270876A1 (en) Anti-hla assay and methods
AU2002350951A1 (en) Assay device and method
AU2003220265A1 (en) Tamperproof and counterfeit-resistant structure
AU2003228397A1 (en) HAUSP-p53 INTERACTION AND USES THEREOF
AU2003224331A1 (en) Insecticides and arachnicides
AU2003292774A1 (en) Novel proteins and use thereof
AU2003280992A1 (en) Novel proteins and use thereof
AU2003216442A1 (en) Enkurin and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase